Haoxi Health Technology Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $537.6K-54.6% YoYTTM through 30 Jun 2025
Net Income $3.9M+200.1% YoYTTM through 30 Jun 2025
Free Cash Flow -$3.4MTTM through 30 Jun 2025
Margins
| Current | |
|---|---|
| Gross Margin | 4.7% |
| EBITDA Margin | -302.8% |
| Operating Margin | -19.8% |
| Net Margin | 721.1% |
Returns
27.1%ROE
18.0%ROA
Balance Sheet Health
Debt / Equity0.10x
Current Ratio3.45x
Net Debt-$7Mnet cash position
Cash & Equivalents$8.6M
Quality Metrics
Altman Z-Score1.04
Piotroski F-Score3 / 9
FCF Margin-632.8%
Multi-Year Trend
RevenueFY2025: $32.8M
Diluted EPS$1.32TTMFY2025: $1.32
Dividend
No dividend
Capital Allocation
R&D Spend$79.5K
Capex Intensity8.2%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.